Ganga Pharmaceuticals Limited (BOM:539680)
13.32
-1.48 (-10.00%)
At close: May 23, 2025
Ganga Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 3.02 | 0.3 | 0.29 | 0.2 | 0.15 | Upgrade |
Cash & Short-Term Investments | 3.02 | 0.3 | 0.29 | 0.2 | 0.15 | Upgrade |
Cash Growth | 913.74% | 2.86% | 41.85% | 40.88% | 24.32% | Upgrade |
Accounts Receivable | 9.11 | 9.23 | 8.89 | 8.92 | 8.2 | Upgrade |
Receivables | 34.45 | 25.13 | 24.01 | 25.47 | 23.57 | Upgrade |
Inventory | 11.82 | 12.41 | 11.83 | 11.5 | 11.33 | Upgrade |
Other Current Assets | 19.37 | 19.66 | 15.35 | 11.91 | 10.84 | Upgrade |
Total Current Assets | 68.67 | 57.5 | 51.47 | 49.08 | 45.88 | Upgrade |
Property, Plant & Equipment | 6.65 | 6.12 | 6.39 | 6.81 | 7.21 | Upgrade |
Long-Term Investments | - | 8.44 | 0.85 | 0.85 | 0.89 | Upgrade |
Other Long-Term Assets | 14.41 | 14.41 | 21.12 | 23.21 | 22.62 | Upgrade |
Total Assets | 89.72 | 86.48 | 79.84 | 79.95 | 76.6 | Upgrade |
Accounts Payable | 2.78 | 1 | 5.81 | 5.26 | 4.41 | Upgrade |
Accrued Expenses | - | 0.66 | 0.51 | 0.59 | 0.53 | Upgrade |
Short-Term Debt | 11.89 | 7.57 | 10.28 | 9.2 | 8.85 | Upgrade |
Current Portion of Long-Term Debt | - | 2.06 | 1.64 | 1.16 | 1.68 | Upgrade |
Current Income Taxes Payable | 0.15 | 0.16 | 0.16 | 0.14 | 0.08 | Upgrade |
Other Current Liabilities | 1.11 | 0.5 | 0.55 | 0.52 | 0.52 | Upgrade |
Total Current Liabilities | 15.93 | 11.95 | 18.95 | 16.86 | 16.06 | Upgrade |
Long-Term Debt | 2.32 | 3.95 | 6.35 | 8.92 | 6.74 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.06 | 0.05 | 0.05 | 0.07 | 0.07 | Upgrade |
Other Long-Term Liabilities | 0.1 | 0 | - | - | 0 | Upgrade |
Total Liabilities | 18.41 | 15.95 | 25.34 | 25.84 | 22.87 | Upgrade |
Common Stock | 48.37 | 48.37 | 40.62 | 40.62 | 40.62 | Upgrade |
Additional Paid-In Capital | - | 7.68 | 6.08 | 6.08 | 6.08 | Upgrade |
Retained Earnings | - | 8.27 | 7.81 | 7.41 | 7.03 | Upgrade |
Comprehensive Income & Other | 22.95 | 6.21 | - | - | - | Upgrade |
Shareholders' Equity | 71.31 | 70.53 | 54.5 | 54.11 | 53.73 | Upgrade |
Total Liabilities & Equity | 89.72 | 86.48 | 79.84 | 79.95 | 76.6 | Upgrade |
Total Debt | 14.21 | 13.58 | 18.26 | 19.28 | 17.27 | Upgrade |
Net Cash (Debt) | -11.19 | -13.28 | -17.97 | -19.07 | -17.12 | Upgrade |
Net Cash Per Share | -1.70 | -2.01 | -4.43 | -4.70 | -4.22 | Upgrade |
Filing Date Shares Outstanding | 5 | 4.84 | 4.06 | 4.06 | 4.06 | Upgrade |
Total Common Shares Outstanding | 5 | 4.84 | 4.06 | 4.06 | 4.06 | Upgrade |
Working Capital | 52.74 | 45.55 | 32.53 | 32.22 | 29.82 | Upgrade |
Book Value Per Share | 14.26 | 14.58 | 13.42 | 13.32 | 13.23 | Upgrade |
Tangible Book Value | 71.31 | 70.53 | 54.5 | 54.11 | 53.73 | Upgrade |
Tangible Book Value Per Share | 14.26 | 14.58 | 13.42 | 13.32 | 13.23 | Upgrade |
Land | - | 2.27 | 2.27 | 2.27 | 2.27 | Upgrade |
Buildings | - | 2.28 | 2.28 | 2.28 | 2.28 | Upgrade |
Machinery | - | 9.14 | 8.92 | 8.77 | 8.62 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.